{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T02:09:10Z","timestamp":1721527750730},"reference-count":21,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T00:00:00Z","timestamp":1205712000000},"content-version":"vor","delay-in-days":5860,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[1992,3]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> One hundred twenty\u2010nine schizophrenic inpatients who were administered zotepine were studied to see if they had zotepine\u2010induced convulsive seizures. Twenty\u2010two patients had grand mal seizures during the administration periods. The incidence of the seizure was 17.1%and was higher than that in previous reports. The average duration of zotepine administration before the seizure was 48.3 days. The incidence of the seizure was closely related to the daily dosage of zotepine, but there was no significant correlation between the daily dosage of zotepine and the duration of administration before the onset of the seizure. The patients who received a combined administration with the higher dose of zotepine and other phenothiazines were revealed to be more likely to have the seizure. In addition, young pateints and patients with a past history of head injuries showed a high incidence of the seizure with the administration of zotepine.<\/jats:p>","DOI":"10.1111\/j.1440-1819.1992.tb00829.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T14:50:24Z","timestamp":1205765424000},"page":"161-167","source":"Crossref","is-referenced-by-count":6,"title":["Convulsive Seizures in Schizophrenic Patients Induced by Zotepine Administration"],"prefix":"10.1111","volume":"46","author":[{"given":"Masashi","family":"Hori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihito","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyasu","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junzo","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,17]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"653","article-title":"A clinical experience of a new neuroleptica, zotepine on schizophrenic patients","volume":"9","author":"Arikawa K.","year":"1980","journal-title":"Jpn J Clin Psychiatry"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1959.73000250001012"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.147.8.1069"},{"key":"e_1_2_1_5_2","first-page":"485","volume":"6","author":"Harada T.","year":"1984","journal-title":"Relation between anti manic effect and activity of zotepine to serotonin (5HT,) receptor. Jpn J Neuropsychopharmacol"},{"key":"e_1_2_1_6_2","first-page":"53","volume":"16","author":"Harada Y.","year":"1987","journal-title":"Electroencephalographic findings in schizophrenic patients treated with zotepine, Jpn J Clin Psychiatry"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.5361\/jkmu1956.31.4_527"},{"key":"e_1_2_1_8_2","first-page":"41","volume":"8","author":"Hirano T.","year":"1986","journal-title":"Mechanisms of the convulsion induced by an antipsychotic drug, Zotepine \u2014 With reference to the GAD activity and the GABA re-uptake. Jpn J Neuropsychopharmacol"},{"key":"e_1_2_1_9_2","first-page":"1460","volume":"244","author":"Itil M.","year":"1980","journal-title":"Epileptogenic side effects of psychotropic drugs. JAMA"},{"key":"e_1_2_1_10_2","first-page":"873","volume":"9","author":"Iwanaga M.","year":"1980","journal-title":"Clinical evaluation of zotepine in chronic schizophrenia \u2014 A multiinstitutional double-blind study in comparison with propericiazine. Jpn J Clin Psychiatry"},{"key":"e_1_2_1_11_2","first-page":"289","volume":"8","author":"Jinbo K.","year":"1980","journal-title":"Zotepine treatment in schizophrenic patients. (author's translation) Jpn Pharmacol Ther"},{"issue":"325","key":"e_1_2_1_12_2","volume":"10","author":"Jorgensen R.S.","year":"1958","journal-title":"The effect of orally administered chlorpromazine on the electroencephalogram in man. Electroencephalogr Clin Neurophysiol"},{"key":"e_1_2_1_13_2","first-page":"843","volume":"22","author":"Kodama R.","year":"1980","journal-title":"Clinical effects of zotepine on schizophrenics. Seishin lgaku"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-195701000-00014"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.20.2.105"},{"key":"e_1_2_1_16_2","first-page":"869","volume":"17","author":"Logothetis J.","year":"1967","journal-title":"Spontaneous epileptic seizures and electroencephalographic changes in the course of phenothiazine therapy. Neurology"},{"key":"e_1_2_1_17_2","first-page":"59","volume":"27","author":"Manmaru S.","year":"1985","journal-title":"Five cases of schizophrenia with convulsive seizures during zotepine administration. Seishin lgaku"},{"key":"e_1_2_1_18_2","first-page":"871","volume":"61","author":"Naoi T.","year":"1959","journal-title":"Electroencephalographic study on the electric convulsive treatment \u2014 The study of latent brain dysfunction by pentazol-activation. Psychiat Neurol Jpn"},{"key":"e_1_2_1_19_2","first-page":"295","volume":"25","author":"Nishizono M.","year":"1983","journal-title":"New aspect of effect of thiepin derivate, zotepine: The correlation between sedative-antimanic effect and reducing effect on level of serum uric acid. Seishin Igaku"},{"key":"e_1_2_1_20_2","first-page":"364","volume":"74","author":"Schlichter W.","year":"1956","journal-title":"Seizures occurring during intensive chlorpromazine therapy. Can Med Assoc J"},{"key":"e_1_2_1_21_2","first-page":"265","volume":"7","author":"Toone B.K.","year":"1977","journal-title":"Epileptic seizures induced by psychotropic drugs. Psychol Med"},{"key":"e_1_2_1_22_2","first-page":"125","volume":"7","author":"Torii H.","year":"1979","journal-title":"Zotepine therapy in schizophrenic patients. (author's translation) Jpn Pharmacol Ther"}],"container-title":["Psychiatry and Clinical Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1819.1992.tb00829.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1819.1992.tb00829.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T12:59:04Z","timestamp":1698065944000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1819.1992.tb00829.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,3]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1992,3]]}},"alternative-id":["10.1111\/j.1440-1819.1992.tb00829.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1819.1992.tb00829.x","archive":["Portico"],"relation":{},"ISSN":["1323-1316","1440-1819"],"issn-type":[{"value":"1323-1316","type":"print"},{"value":"1440-1819","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,3]]}}}